1282742-29-3 Usage
Uses
Used in Pharmaceutical Synthesis:
Tert-butyl 3-(isopropylamino)piperidine-1-carboxylate is utilized as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure and reactivity contribute to the development of new drug molecules, enhancing the therapeutic potential of medications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, tert-butyl 3-(isopropylamino)piperidine-1-carboxylate serves as a building block for the creation of complex organic molecules. Its incorporation into molecular frameworks allows for the exploration of new chemical spaces and the discovery of innovative therapeutic agents.
Used in Organic Synthesis:
As a reagent in organic synthesis, tert-butyl 3-(isopropylamino)piperidine-1-carboxylate is employed to facilitate various chemical reactions. Its stable properties make it a reliable component in the synthesis of a wide range of organic compounds.
Used in Drug Development:
Tert-butyl 3-(isopropylamino)piperidine-1-carboxylate is also used in the development of new drugs. Its presence in the synthesis process can lead to the creation of molecules with improved pharmacological properties, such as enhanced efficacy, selectivity, and reduced side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 1282742-29-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,2,7,4 and 2 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1282742-29:
(9*1)+(8*2)+(7*8)+(6*2)+(5*7)+(4*4)+(3*2)+(2*2)+(1*9)=163
163 % 10 = 3
So 1282742-29-3 is a valid CAS Registry Number.
1282742-29-3Relevant articles and documents
HETEROCYCLIC TYROSINE KINASE INHIBITORS
-
Page/Page column 115-116, (2012/05/19)
The present invention provides compounds useful as inhibitors of Tec family kinases, compositions thereof, and methods of using the same. In certain embodiments, the present invention provides pharmaceutical formulations comprising provided compounds. In certain embodiments, the present invention provides a method of decreasing enzymatic activity of a Tec kinase family member. In some embodiments, such methods include contacting a Tec kinase family member with an effective amount of a Tec kinase family member inhibitor. In certain embodiments, the present invention provides a method of treating a disorder responsive to Tec kinase family inhibition in a subject in need thereof.
